Non-invasive rejection surveillance in stable heart transplantation using local laboratory-run donor-derived cell-free DNA assay: two-centre European feasibility study

Back

ESC Professional Premium Access

Non-invasive rejection surveillance in stable heart transplantation using local laboratory-run donor-derived cell-free DNA assay: two-centre European feasibility study

Session: Advanced heart failure therapies: transplant and MCS

Topic: Heart Transplantation

Speaker: Doctor T. Teszak (Budapest, HU)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Timea Teszak

Semmelweis University, Budapest (Hungary)

0 follower

5 more presentations in this session

Predictors on admission associated with successful weaning and in - hospital mortality in patients with refractory shock undergoing veno - arterial extracorporeal membrane oxygenation

Speaker: Associate Professor J. Hong (Anyang-Si- Gyeonggi-Do, KR)

Outcomes of pediatric ventricular assist device in the United States: an analysis of the national inpatient sample database

Speaker: Doctor M. Hamzah (Doha, QA)

Clinical relevance and outcome of routine endomyocardial biopsy to detect rejection after heart transplantation

Speaker: Doctor M. Oerlemans (Utrecht, NL)

Elevated lipoprotein a level in heart transplant patients is associated with cardiac allograft vasculopathy

Speaker: Mr D. Enriquez Vazquez (A Coruna, ES)

Predictors and outcomes of rejection requiring treatment within the first year following heart transplantation

Speaker: Doctor A. Briasoulis (Athens, GR)

Access

Abstract

Slides

Access the full session

Advanced heart failure therapies: transplant and MCS

Speakers: Doctor T. Teszak, Associate Professor J. Hong, Doctor M. Hamzah, Doctor M. Oerlemans, Mr D. Enriquez Vazquez...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources